Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Self-blinding citizen science to explore psychedelic microdosing
Balázs Szigeti, Laura Kärtner, Allan Blemings, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 138

Showing 26-50 of 138 citing articles:

From psychiatry to neurology: Psychedelics as prospective therapeutics for neurodegenerative disorders
Urszula Kozłowska, Charles D. Nichols, Kalina Wiatr, et al.
Journal of Neurochemistry (2021) Vol. 162, Iss. 1, pp. 89-108
Open Access | Times Cited: 52
Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study
Josephine Marschall, George Fejer, Pascal Lempe, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 1, pp. 97-113
Open Access | Times Cited: 52
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
Kate Corrigan, Maeve Haran, Conor McCandliss, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 3, pp. 1385-1397
Open Access | Times Cited: 46
Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
Robin Carhart‐Harris, Anne Catherine Wagner, Manish Agrawal, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 1, pp. 6-11
Open Access | Times Cited: 42
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
Joseph M. Rootman, Maggie Kiraga, Pamela Kryskow, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Classic and non‐classic psychedelics for substance use disorder: A review of their historic, past and current research
Fúlvio Rieli Mendes, Cristiane dos Santos Costa, Victor Distefano Wiltenburg, et al.
Addiction Neuroscience (2022) Vol. 3, pp. 100025-100025
Open Access | Times Cited: 33
LSD, afterglow and hangover: Increased episodic memory and verbal fluency, decreased cognitive flexibility
Isabel Wießner, Rodolfo Olivieri, Marcelo Falchi, et al.
European Neuropsychopharmacology (2022) Vol. 58, pp. 7-19
Closed Access | Times Cited: 32
Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans
Flora Moujaes, Katrin H. Preller, Jie Lisa Ji, et al.
Biological Psychiatry (2022) Vol. 93, Iss. 12, pp. 1061-1070
Open Access | Times Cited: 31
The value of real world evidence: The case of medical cannabis
Anne Katrin Schlag, Rayyan Zafar, Michael T. Lynskey, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 29
Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review
Oliver Rumle Hovmand, Emil Deleuran Poulsen, Sidse Arnfred, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 649-659
Open Access | Times Cited: 20
Cardiovascular safety of psychedelic medicine: current status and future directions
Agnieszka Wsół
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1362-1380
Open Access | Times Cited: 20
The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
Balázs Szigeti, David Nutt, Robin Carhart‐Harris, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Psilocybin’s effects on cognition and creativity: A scoping review
Justin N Bonnieux, Baeleigh VanderZwaag, Zahra Premji, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 635-648
Open Access | Times Cited: 17
Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats
Kat F. Kiilerich, Joe Lorenz, Malthe B. Scharff, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3829-3841
Open Access | Times Cited: 17
Keeping the promise: a critique of the current state of microdosing research
Rotem Petranker, Thomas Anderson, Emily C. Fewster, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy
Seetal Dodd, Trevor R. Norman, Harris A. Eyre, et al.
CNS Spectrums (2022) Vol. 28, Iss. 4, pp. 416-426
Open Access | Times Cited: 24
Psilocybin history, action and reaction: A narrative clinical review
Pravesh Sharma, Quang A. Nguyen, Sadie J. Matthews, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 9, pp. 849-865
Closed Access | Times Cited: 13
Predicting the Intensity of Psychedelic-Induced Mystical and Challenging Experience in a Healthy Population: An Exploratory Post-Hoc Analysis
Kwonmok Ko, Ben Carter, Anthony J. Cleare, et al.
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 2105-2113
Open Access | Times Cited: 13
Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
Vince Polito, Paul Liknaitzky
Journal of Psychopharmacology (2024) Vol. 38, Iss. 8, pp. 701-711
Open Access | Times Cited: 4
Side Effects of Microdosing Lysergic Acid Diethylamide and Psilocybin: A Systematic Review of Potential Physiological and Psychiatric Outcomes
Stefan Modzelewski, Anna Stankiewicz, Napoleon Waszkiewicz, et al.
Neuropharmacology (2025), pp. 110402-110402
Closed Access
Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults
Lorenz Mueller, Joyce Santos de Jesus, Yasmin Schmid, et al.
JAMA Psychiatry (2025)
Closed Access
Do undergraduates’ views of psychedelics relate to the context for psychedelic use?
Dan Petrovitch, Jason Van Allen, Sean M. Mitchell, et al.
Drug Science Policy and Law (2025) Vol. 11
Closed Access
Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?
Iva Totomanova, Eline Haijen, Petra P.M. Hurks, et al.
International review of neurobiology (2025)
Closed Access
Recent trends in the management of depression in persons with cancer
Aliza A. Panjwani, Madeline Li
Current Opinion in Psychiatry (2021) Vol. 34, Iss. 5, pp. 448-459
Closed Access | Times Cited: 28
Psilocybin Efficacy and Mechanisms of Action in Major Depressive Disorder: a Review
Damien Prouzeau, Ismaël Conejero, Peter L. Voyvodic, et al.
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 573-581
Closed Access | Times Cited: 20

Scroll to top